Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Millionaire Players Club called ARFR this morning at .01. Thank God I listened!
They are awesome
http://www.investorshub.com/boards/board.asp?board_id=5414
ARFR shor sqeeze comming?
is that what you saying by the buynet???
ARFR this news is great should see the stock moving on it
great pick
ARFR going nuts on the news of free debt
SAN CLEMENTE, Calif., March 31, 2006 (PRIMEZONE) -- Advanced Refractive Technologies, Inc. (ART) (OTCBB:ARFR) is pleased to announce that Phase 1 Holdings LLC (PH1), a New York Based Holding Company, has acquired approximately 70% ($4,513,600) of the outstanding convertible debentures issued by ART and currently outstanding. PH1 has agreed to waive all delinquent interest and penalties that ART has incurred to date on the acquired debentures. In addition, all warrants associated with the acquired debentures have been cancelled. PHI has advised ART that it plans to continue to negotiate to purchase the balance of the outstanding debentures.
George Haralampoudis, the managing partner of PH1, said, "Phase 1 Holdings stands prepared to assist ART in its future fund raising efforts in order to raise the necessary capital to retire the acquired debentures, as well as to fund future acquisitions of new technology in the ophthalmic field, and raise all necessary working capital."
Mr. Haralampoudis continued, "Phase 1 Holdings is confident in the potential future success of ART in obtaining and developing new cutting edge technology in the growing ophthalmic medical device and medicinal markets."
Randal Bailey, the CEO of ART, stated, "We at Advanced Refractive Technologies, Inc. are pleased that PH1 has agreed to assist the Company and we look forward to working with them in the future." He emphasized that this represented a significant advance in ART reducing and restructuring its debt and assisting in implementing its business plan.
About Advanced Refractive Technologies, Inc.
Advanced Refractive Technologies, Inc. is a medical device company focused on the development and marketing of innovative ophthalmic applications that will result in faster, safer and more effective procedures in two of the largest surgical markets in the world: corrective refractive surgery and cataract surgery. The Company is also entering the area of drug discovery through strategic licensing opportunities. Advanced Refractive Technologies is also in the process of developing their Accupulse, a next generation cataract emulsifier, which utilizes the company's proprietary waterjet technology. The Accupulse cataract emulsifier, currently under development, is a device that uses pulsed waterjet technology to remove cataracts -- the most frequently performed surgical procedure in the world. For more information on Advanced Refractive Technologies, please visit its website at www.advancedrefractive.com
The Advanced Refractive Technologies, Inc. logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2498
CONTACT: Advanced Refractive Technologies, Inc.
Lawrence Schreiber
(949) 940-1300
fax: (949) 940-1301
www.advancedrefractive.com
ARFR looking very good here on the news of free debt
SAN CLEMENTE, Calif., March 31, 2006 (PRIMEZONE) -- Advanced Refractive Technologies, Inc. (ART) (OTCBB:ARFR) is pleased to announce that Phase 1 Holdings LLC (PH1), a New York Based Holding Company, has acquired approximately 70% ($4,513,600) of the outstanding convertible debentures issued by ART and currently outstanding. PH1 has agreed to waive all delinquent interest and penalties that ART has incurred to date on the acquired debentures. In addition, all warrants associated with the acquired debentures have been cancelled. PHI has advised ART that it plans to continue to negotiate to purchase the balance of the outstanding debentures.
George Haralampoudis, the managing partner of PH1, said, "Phase 1 Holdings stands prepared to assist ART in its future fund raising efforts in order to raise the necessary capital to retire the acquired debentures, as well as to fund future acquisitions of new technology in the ophthalmic field, and raise all necessary working capital."
Mr. Haralampoudis continued, "Phase 1 Holdings is confident in the potential future success of ART in obtaining and developing new cutting edge technology in the growing ophthalmic medical device and medicinal markets."
Randal Bailey, the CEO of ART, stated, "We at Advanced Refractive Technologies, Inc. are pleased that PH1 has agreed to assist the Company and we look forward to working with them in the future." He emphasized that this represented a significant advance in ART reducing and restructuring its debt and assisting in implementing its business plan.
About Advanced Refractive Technologies, Inc.
Advanced Refractive Technologies, Inc. is a medical device company focused on the development and marketing of innovative ophthalmic applications that will result in faster, safer and more effective procedures in two of the largest surgical markets in the world: corrective refractive surgery and cataract surgery. The Company is also entering the area of drug discovery through strategic licensing opportunities. Advanced Refractive Technologies is also in the process of developing their Accupulse, a next generation cataract emulsifier, which utilizes the company's proprietary waterjet technology. The Accupulse cataract emulsifier, currently under development, is a device that uses pulsed waterjet technology to remove cataracts -- the most frequently performed surgical procedure in the world. For more information on Advanced Refractive Technologies, please visit its website at www.advancedrefractive.com
The Advanced Refractive Technologies, Inc. logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2498
CONTACT: Advanced Refractive Technologies, Inc.
Lawrence Schreiber
(949) 940-1300
fax: (949) 940-1301
www.advancedrefractive.com
millionaire club good call on when to sell efsf!!!
now i will add more GMED!!!!
GOOD JOB
GMED----HUGE
GMED LOOKS GOOD
EFSF gonna blow like EGEI
AMAZING NEWS OUT ON THE BIRD FLU FRONT
GONNA EXPLODE
GRLC hod at .005 LOOKING GOOD
GRLC watch it closly
DKAM...NICE INFORMATION HERE IN THE 10K THAT IS JUST OUT
CHECK OUT THE FUTURE REVENUES THEY MENTIONED HERE
$300,00+$137,000+$500,000+$3,120,000(ONLY FOR THE FIRST Q MORE TO COME)=$4,057,000 IN SELLS thats increadible...i say they could top more then 7.5million next year compare to the 2million they made all this year...could be a huge year for DKAM
The company has commenced developing, designing and pre-selling Trump Vodka. Milton Glaser a world famous designer has been retained by Drinks Americas to design the Trump Vodka packaging. Gotham a division of Interpublic has been retained to develop a national advertising campaign for the Trump Vodka. Drinks has commenced presenting the sales program to distributors. To date five distributors in the North East United States have been appointed for the product and have submitted purchase orders for in excess of 26,000 six pac cases of Trump representing $3,120,000 of business to be shipped in the first quarter of Drinks fiscal year.
The company was also successful in its launch of Newman's Own Sparkling Fruit Drinks within the Metro New York and surrounding markets. The company anticipates that Newman's Own single serve products will expand to a line of fruit teas and sparkling waters to be introduced in early 2006. The company is also planning on expanding the product line geographically beyond the original expansion markets.
The company has also launched a fine wine division, Drinks International Select Wines. This company was formed to market superior own label wines to the top 100 retail accounts in the US. In January of 2006 the company participated in an international wine buying trip it conducted with five of these key customers. The company anticipates that $300,000 in future wine orders through the first two Drinks quarters will result from this event.
7
--------------------------------------------------------------------------------
The company is continuing to expand Damiana sales nationally with 1,116 cases sold generating $137,000 in business year to date. Drinks believe that Damiana sales will continue to expand nationally targeting Hispanic market growth and points of distribution. The company plans to promote Damiana as a natural addition of Margarita cocktails and to co market the brand with its Aguila Tequila.
The company acquired the licensing rights to Rheingold Beer and is currently restaging and redesigning product. Drinks has entered into a clothing and merchandise licensing agreement for the Rheingold trademark and has entered into a contract with J2 marketing guarantying the company $500,000 in licensing payments for Rheingold merchandise over an 18 month period.
I am waiting for the q results on ISCR
ISCR results should be out on march 31 i cant wait to see them and see which direction ISCR is going....hopefully all the revenues that they generated during the year will show some profitabilty
lets see what and where it takes us
SHAR NEXT TIME IT RUNS OVER .01 WATCH OUT
SHAR ROUND 2 IS COMMING SELLERS ARE GONE
WATCH IT CLOSLY HERE
shar .09bid .095 ask we should see above a .01 open
in my opinion
SHAR IS GAPPING THIS MORNING LETS OPEN ABOVE A PENNY!!!!
SHAR LOW...MEGA LOW FLAOTER...SHOULD MOVE HIGHER
.008 GREAT CALL MILLIONAIRE PLAYERS CLUB
DKAM NOW .90 LONG TERM PLAY BY THE MILLIONAIRE PLAYERS CLUB
WEEEEEEEEEEEEEEEEEEEEE
NMKT LOOKING GOOD!!!
they had news today regarding move revenues watch it closly
DKAM NEWS TODAY ADDITIONAL 2.5MILLION IN REVENUES TO THIS LOW...LOW FLOATER.....THIS COMPANY IS INVOLVED WITH DONALD TRUMP....SO WATCH FOR THE BIG BOYS TO COME IN SOON ON IT
IPLY .04 NICE!!!!
IPLY LOW FLOAT
IPLY GREAT PRODUCT
IPLY GOLDEN CROSS
IPLY I LIKE IT....I LIKE IT ALOT
DKAM NEWS OUT...THIS STOCK WILL RETIRE PEOPLE
WAIT UNTIL THE T &T DRINK KNOWN AS DONALD AND TRUMP COMES OUT!!!
WILL BE AMAZING
10.00 IN THE FUTURE IN MY OPINION
Sales of at Least $2.5 Million of Rheingold Related Merchandise Expected 2006 Paying Drinks Americas $500,000 in Coming Year
Drinks Americas Holdings, Ltd. (OTC BB: DKAM) ("Drinks Americas" or the "Company") today announced that it has executed an agreement with J2 Bell Licensing Group LLC, a well known national product licensing and merchandising company, that will guarantee payments to Drinks Americas of at least $500,000 in the coming year driven by strong retail acceptance of the recently launched Rheingold line of hats, clothing and glassware.
Rheingold's licensed hat and t-shirt line recently produced by Drew Pearson, founder of the Pearson Group, was shown for the first time at the MAGIC Show in Las Vegas at the end of February. Pearson projects that the company will do as much as $ 2 million in clothing sales with the Rheingold line. Since that time, initial response to the line has been very positive. The national retailer LIDS, with 450 locations across the United States, was the first chain to place an order for Rheingold hats. LIDS operates under the LIDS, Hatzone and Hatworld tradenames at retail locations across the United States.
Jim Bell, CEO of J2Bell, stated, "The Rheingold brand with the New York connection and nostalgic art is a fit with current retail trends. The lids product will be available in April and additional retail placements will follow."
J. Patrick Kenny, CEO of Drinks, stated, "Drinks Americas' strong early sales of Rheingold hats and t-shirts reinforce the value of our icon brand portfolio. People know Rheingold; it is a New York icon. These sales support and reinforce the brand. Sales of Rheingold Beer shirts, hats and glassware in retail outlets across the country reinforce our brand marketing efforts. The LIDS order will provide us with immediate national exposure of the Rheingold brand," added Mr. Kenny.
In October of 2005, Drinks Americas acquired Rheingold Beer, which has been famous in New York since 1883. After Prohibition, the brand became even more celebrated particularly during the '40s, '50s and '60s, thanks in part to its Miss Rheingold promotions. For those three decades, Rheingold was the most requested beer in New York City.
Drinks Americas develops, owns, markets, and nationally distributes alcoholic and non-alcoholic premium beverages that are often associated with renowned icon celebrities. Drinks' portfolio of premium alcoholic beverages includes Donald Trump's Trump Super Premium Vodka, Willie Nelson's Old Whiskey River Bourbon and Bourbon Cream and Roy Yamaguchi's Y Sake. Drinks non alcoholic brands include the distribution of Paul Newman's Own Lightly Sparkling Fruit Juice Drinks.
Other products owned and distributed by Drinks include Damiana, the Mexican liqueur, Aguila Tequila; Norman's Wines from Australia's oldest winery, Drinks' award-winning Cohete Rum Guarana from Panama, Swiss T and Rheingold Beer. Damiana, Old Whiskey River, Y Sake, Aguila Tequila and Cohete Rum are Gold and Silver Medal award winners respectively from the International Beverage Tasting Institute and the San Francisco International Wine and Spirits Competition.
For further information, please visit our website at www.drinksamericas.com.
--------------------------------------------------------------------------------
Distributed by Market Wire
Investor Relations Contacts:
DKAM I HAVE BEEN FOLLOWING IT SINCE .45 I BOUGHT SOME AT .45 SOME AT .60 WILL HOLD FOR LONG TERM....I THINK DONALD TRUMP DRINK WILL BE A GOOD ONE
GOOD LUCK